Induction of prolonged survival of CD4⁺ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients
J. Clin. Invest. Joseph A. Kovacs, et al. 115:2139 doi:10.1172/JCI23196 [Go to this article.]

Table 1
Patient characteristics at the time of labeling